Open AccessLow Rate of Clinically Evident Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with a Complement C5 Inhibitor: Results from a Large, Multicenter, US Real-World Study
Author(s) -
Jamile M. Shammo,
Ajeet Gajra,
Yogesh C. Patel,
Ioannis Tomazos,
Jonathan Kish,
Anita Hill,
J. Rafael Sierra,
David J. Araten
Publication year - 2022
Publication title -
journal of blood medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.676
H-Index - 18
ISSN - 1179-2736
DOI - 10.2147/jbm.s361863
Subject(s) - paroxysmal nocturnal hemoglobinuria , eculizumab , medicine , hemolysis , hemoglobinuria , anemia , hemoglobin , bone marrow failure , gastroenterology , concomitant , bone marrow , surgery , immunology , complement system , antibody , stem cell , haematopoiesis , biology , genetics